Nancy E. Davidson
Impact in
- Cancer Research top 0.02%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.01%
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
- Cancer-related Molecular Pathways
Papers in
- Oncology 156
- HER2/EGFR in Cancer Research 62
- Cancer Treatment and Pharmacology 44
-
- Epigenetics and DNA Methylation 57
- Histone Deacetylase Inhibitors Research 30
- Cancer-related gene regulation 25
- Co-authors
- Edith A. Perez (50 shared papers)James D. Yager (2 shared papers)Yvonne Ottaviano (6 shared papers)Stephen B. Baylin (10 shared papers)Silvana Martino (48 shared papers)Julie R. Gralow (21 shared papers)Jean‐Pierre J. Issa (5 shared papers)Molin Wang (6 shared papers)
- Journals
- Journal of Clinical Oncology (93 papers)Cancer Research (22 papers)Breast Cancer Research and Treatment (22 papers)Clinical Cancer Research (13 papers)JNCI Journal of the National Cancer Institute (10 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Nancy E. Davidson
406 papers receiving 41.6k citations
Nancy E. Davidson's Hit Papers
Peers
Comparison fields: 5 of 185
- Cancer Research 10.6k
- Oncology 17.1k
- Genetics 6.7k
- Molecular Biology 16.6k
- Pathology and Forensic Medicine 2.6k
Countries citing papers authored by Nancy E. Davidson
This map shows the geographic impact of Nancy E. Davidson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy E. Davidson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy E. Davidson more than expected).
Fields of papers citing papers by Nancy E. Davidson
This network shows the impact of papers produced by Nancy E. Davidson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy E. Davidson. The network helps show where Nancy E. Davidson may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy E. Davidson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 414 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer Hit paper breakdown → | 2007 | 2465 |
| 2 | Mutations in the p53 gene occur in diverse human tumour types Hit paper breakdown → | 1989 | 2458 |
| 3 | Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Hit paper breakdown → | 1993 | 1734 |
| 4 | Estrogen Carcinogenesis in Breast Cancer Hit paper breakdown → | 2006 | 1494 |
| 5 | Inactivation of the CDKN2/p16/MTS1 gene is frequently associated with aberrant DNA methylation in all common human cancers. Hit paper breakdown → | 1995 | 1194 |
| 6 | Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon Hit paper breakdown → | 1994 | 1049 |
| 7 | Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199 Hit paper breakdown → | 2014 | 979 |
| 8 | Randomized Trial of Letrozole Following Tamoxifen as Extended Adjuvant Therapy in Receptor-Positive Breast Cancer: Updated Findings from NCIC CTG MA.17 Hit paper breakdown → | 2005 | 868 |
| 9 | Weekly Paclitaxel in the Adjuvant Treatment of Breast Cancer Hit paper breakdown → | 2008 | 709 |
| 10 | Trastuzumab Plus Adjuvant Chemotherapy for Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Planned Joint Analysis of Overall Survival From NSABP B-31 and NCCTG N9831 Hit paper breakdown → | 2014 | 708 |
| 11 | E-cadherin expression is silenced by DNA hypermethylation in human breast and prostate carcinomas. Hit paper breakdown → | 1995 | 701 |
| 12 | American Society of Clinical Oncology Clinical Practice Guideline: Update on Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer Hit paper breakdown → | 2010 | 635 |
| 13 | Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update Hit paper breakdown → | 2014 | 592 |
| 14 | Four-Year Follow-Up of Trastuzumab Plus Adjuvant Chemotherapy for Operable Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: Joint Analysis of Data From NCCTG N9831 and NSABP B-31 Hit paper breakdown → | 2011 | 562 |
| 15 | Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms With Outcome in a Trial of Paclitaxel Compared With Paclitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100 Hit paper breakdown → | 2008 | 502 |
| 16 | Breast Cancer Follow-Up and Management After Primary Treatment: American Society of Clinical Oncology Clinical Practice Guideline Update Hit paper breakdown → | 2012 | 462 |
| 17 | Adjuvant Endocrine Therapy for Women With Hormone Receptor–Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update Hit paper breakdown → | 2018 | 427 |
| 18 | 2008 | 423 | |
| 19 | Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. | 1994 | 419 |
| 20 | 2006 | 418 |
About Nancy E. Davidson
Nancy E. Davidson is a scholar working on Oncology, Molecular Biology, Cancer Research, Genetics and Pulmonary and Respiratory Medicine, having authored 414 papers that have together received 43.1k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (109 papers), HER2/EGFR in Cancer Research (62 papers), Estrogen and related hormone effects (61 papers), Epigenetics and DNA Methylation (57 papers), Cancer Treatment and Pharmacology (44 papers), Histone Deacetylase Inhibitors Research (30 papers), Advanced Breast Cancer Therapies (26 papers) and Cancer-related gene regulation (25 papers). The work is most often cited by research in Cancer Research (10.6k citations), Oncology (17.1k citations), Genetics (6.7k citations), Molecular Biology (16.6k citations) and Pathology and Forensic Medicine (2.6k citations). Nancy E. Davidson has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Edith A. Perez, James D. Yager, Yvonne Ottaviano, Stephen B. Baylin, Silvana Martino, Julie R. Gralow, Jean‐Pierre J. Issa, Molin Wang, Scott H. Kaufmann and Rena G. Lapidus. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Breast Cancer Research and Treatment, Clinical Cancer Research and JNCI Journal of the National Cancer Institute.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.